Top Gene therapy Stocks in South Korea
Browse the largest South Korea companies in the world ranked by their Market Capitalization. Global Gene therapy Companies in South Korea market cap is $2.04B.
19 Dec 2024, 16:04 UTC
Companies: 15
🇰🇷1 |  | $16.15 | -1.68% | 749.93M | 2.85% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷2 |  | $13.43 | -3.94% | 296.68M | -41.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷3 |  | $10.72 | -6.20% | 209.71M | -7.38% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷4 |  | $3.76 | -5.04% | 124.78M | -37.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷5 |  | $1.40 | -3.33% | 109.39M | -28.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷6 |  | $12.77 | -5.45% | 83.09M | 27.67% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷7 |  | $4.98 | -29.91% | 78.35M | 6.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷8 |  | $3.65 | -2.75% | 68.87M | -52.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷9 |  | $9.66 | -3.11% | 65.69M | -5.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷10 |  | $2.25 | 29.82% | 62.76M | -24.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷11 |  | $3.39 | -0.10% | 32.57M | -13.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷12 |  | $1.06 | -3.75% | 30.64M | -78.28% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷13 |  | $5.71 | -0.72% | 28.79M | -4.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷14 |  | $2.35 | 0.00% | 19.65M | -21.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷15 |  | $0.63 | -0.44% | 16.30M | -25.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
